Currently, the “thrombotic microangiopathy” has been designated when thrombocytopenia and MAHA are present without severe ADAMTS13 deficiency in an acquired medical condition. The gene discussed is ADAMTS13; the disease is hyperinsulinemic hypoglycemia, familial, 4.